Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergy to cocamide DEA

J F Fowler1

  • 1University of Louisville School of Medicine, Department of Medicine, Louisville, KT 40202, USA.

American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society
|April 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000-2016.

The British journal of dermatology·2021
Same author

Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches.

The British journal of dermatology·2018
Same author

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Hyperfractionated radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014
Same author

The effect of multiple small doses of X rays on skin reactions in the mouse and a basic interpretation. 1976.

Radiation research·2012
Same author

21 years of biologically effective dose.

The British journal of radiology·2010
Same journal

ACDS President's message. An important period in the history of our Society.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2004
Same journal

Label dermatitis.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2004
Same journal

Considerations for testing irritancy, allergy, and photoreactivity in fragrance safety evaluations.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2004
Same journal

Barrier creams: fact or fiction.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2004
Same journal

Common shoe allergens undetected by commercial patch-testing kits: dithiodimorpholine and isocyanates.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2004
Same journal

Dermatitis artefacta?

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2004
See all related articles

Cocamide DEA (coconut diethanolamide) can cause allergic contact dermatitis. This uncommon allergen is often found in personal care products and may affect individuals with pre-existing skin allergies.

Area of Science:

  • Dermatology
  • Allergology
  • Toxicology

Background:

  • Cocamide DEA (coconut diethanolamide) is a common surfactant used in personal care products.
  • Contact dermatitis is a prevalent skin condition with various potential triggers.

Observation:

  • Three cases of allergic contact dermatitis to cocamide DEA are presented.
  • Two patients exhibited multiple co-existing cutaneous allergies.
  • Exposure to cocamide DEA was linked to personal care product usage in two cases and occupational exposure in one.

Findings:

  • Cocamide DEA is identified as an uncommon but significant allergen.
  • Individuals with multiple skin allergies may be more susceptible to cocamide DEA allergy.
  • Patch testing can confirm cocamide DEA as a contact allergen.

Related Experiment Videos

Implications:

  • Awareness of cocamide DEA as a potential allergen is crucial for dermatologists and allergists.
  • Product formulation review may be necessary to identify and potentially replace cocamide DEA.
  • Patient education on ingredient awareness can aid in managing allergic contact dermatitis.